| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Knopp Kevin J. | President and CEO, Director | C/O 908 DEVICES INC, 44 3RD AVENUE, BURLINGTON | /s/ Mark S. Levine, Attorney-in-Fact | 03 Feb 2026 | 0001836523 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MASS | Common Stock | Options Exercise | +11,255 | +1.6% | 733,988 | 01 Feb 2026 | Direct | F1 | ||
| transaction | MASS | Common Stock | Options Exercise | +13,449 | +1.8% | 747,437 | 01 Feb 2026 | Direct | F1 | ||
| transaction | MASS | Common Stock | Options Exercise | +17,007 | +2.3% | 764,444 | 01 Feb 2026 | Direct | F1 | ||
| transaction | MASS | Common Stock | Options Exercise | +66,288 | +8.7% | 830,732 | 01 Feb 2026 | Direct | F1 | ||
| transaction | MASS | Common Stock | Sale | $214,842 | -34,764 | -4.2% | $6.18 | 795,968 | 02 Feb 2026 | Direct | F2, F3 |
| holding | MASS | Common Stock | 541,223 | 01 Feb 2026 | See footnote | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MASS | Restricted Stock Units | Options Exercise | $0 | -11,255 | -100% | $0.000000 | 0 | 01 Feb 2026 | Common Stock | 11,255 | Direct | F1, F5 | |
| transaction | MASS | Restricted Stock Units | Options Exercise | $0 | -13,449 | -50% | $0.000000 | 13,448 | 01 Feb 2026 | Common Stock | 13,449 | Direct | F1, F6 | |
| transaction | MASS | Restricted Stock Units | Options Exercise | $0 | -17,007 | -33% | $0.000000 | 34,014 | 01 Feb 2026 | Common Stock | 17,007 | Direct | F1, F7 | |
| transaction | MASS | Restricted Stock Units | Options Exercise | $0 | -66,288 | -33% | $0.000000 | 132,576 | 01 Feb 2026 | Common Stock | 66,288 | Direct | F1, F8 | |
| transaction | MASS | Restricted Stock Units | Award | $0 | +205,978 | $0.000000 | 205,978 | 02 Feb 2026 | Common Stock | 205,978 | Direct | F1, F9 | ||
| transaction | MASS | Stock Option (option to buy) | Award | $0 | +90,043 | $0.000000 | 90,043 | 02 Feb 2026 | Common Stock | 90,043 | $6.19 | Direct | F10 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. |
| F2 | The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.105 to $6.32, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F4 | The shares are owned directly by The Kevin J. Knopp Irrevocable Trust of 2018. The reporting person's brother-in-law is the trustee of The Kevin J. Knopp Irrevocable Trust of 2018 and has sole voting and dispositive control with respect to all securities held by such trust. The reporting person may be deemed to be the beneficial owner of the securities held by The Kevin J. Knopp Irrevocable Trust of 2018. |
| F5 | These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2022, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. |
| F6 | These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. |
| F7 | These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. |
| F8 | The RSUs shall vest one-third on February 1, 2026, with the remaining two-thirds vesting in two substantially equal annual installments at the two anniversary dates following February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. |
| F9 | The RSUs shall vest one-third on February 1, 2027, with the remaining two-thirds vesting in two substantially equal annual installments at the two anniversary dates following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date. |
| F10 | One-third of the shares underlying the option become vested and exercisable on February 1, 2027, and the remaining two-thirds of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 24 months following February 1, 2027, subject to the reporting person's continued service through the applicable vesting date. |